Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines
Open accessThe DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Understanding how hepatitis C virus (HCV) induces and circumvents the host's natural killer (NK) cell-mediated immunity is of critical importance in efforts to design effective therapeutics. We report here the decreased expression of the NKG2D activating receptor as a novel strategy adopted by HCV to evade NK-cell mediated responses. We show that chronic HCV infection is associated with expression of ligands for NKG2D, the MHC class I-related Chain (MIC) molecules, on hepatocytes. However, NKG2D expression is downmodulated on circulating NK cells, and consequently NK cell-mediated cytotoxic capacity and interferon-γ production are impaired. Using an endotoxin-free recombinant NS5A protein, we show that NS5A stimulation of monocytes through Toll-like Receptor 4 (TLR4) promotes p38- and PI3 kinase-dependent IL-10 production, while inhibiting IL-12 production. In turn, IL-10 triggers secretion of TGFβ which downmodulates NKG2D expression on NK cells, leading to their impaired effector functions. Moreover, culture supernatants of HCV JFH1 replicating Huh-7.5.1 cells reproduce the effect of recombinant NS5A on NKG2D downmodulation. Exogenous IL-15 can antagonize the TGFβ effect and restore normal NKG2D expression on NK cells. We conclude that NKG2D-dependent NK cell functions are modulated during chronic HCV infection, and demonstrate that this alteration can be prevented by exogenous IL-15, which could represent a meaningful adjuvant for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 NS5A induces IL-10 and suppresses IL-12 production by monocytes through TLR4-mediated activation of p38 and PI3 kinase signaling. A) Left panel: Control monocytes (0.1×106/ml) were cultured in medium alone, or in the presence of NS4 (0.5 µg/ml), NS5A (0.5 µg/ml), LPS (1 µg/ml), or NS5A+LPS for 24 hr, and cell supernatants were analyzed for IL-10 by ELISA. Data are expressed as the mean ± SEM of three independent experiments. * P = 0.01. Right panel: Monocytes were pretreated with IL-10 neutralizing mAb or soluble IL-10 receptor prior to stimulation with NS5A, and TGFβ levels in the culture supernatants were quantified by ELISA. Results are expressed as index of inhibition of NS5A-mediated TGFβ levels, calculated as: [(TGFβ (NS5A) - TGFβ (NS5A+mAb))/TGFβ (NS5A) - TGFβ (medium)]x100, and are the mean ± SEM of three independent experiments. * P = 0.02, ** P = 0.0005. B) For IL-12p70 production, monocytes were first primed by IFNγ for 16 h and then stimulated with LPS (1 µg/ml), HCV-NS5A (0.5 µg/ml) or both for 24 hr, after which supernatants were analyzed for IL-12 by ELISA. Data are expressed as the mean ± SEM of three independent experiments. * P = 0.02, ** P = 0.001. C) Purified monocytes were pretreated with 5 µg/ml of anti-TLR4, -TLR2 or -CD14 neutralizing antibodies prior to 24 hr stimulation with 0.5 µg/ml of NS5A, after which IL-10 levels in the supernatants were measured by ELISA. Results are the mean ± SEM of IL-10 levels from mean replica values in 3 independent experiments. * P = 0.02, ** P = 0.01. D) Binding of NS5A to monocytes. Control monocytes were incubated for 30 min at 4°C with 0.5 µg/ml of recombinant NS5A, NS4 or medium alone. Binding of NS5A to monocytes was revealed by staining with anti-NS5A 9E10 antibody and flow cytometry analysis. Results are expressed as the percentage of positive cells, and are the mean of 4 independent experiments. E) Monocytes were left untreated, or treated with JNK inhibitor (SP600125, 10 µM), MEK inhibitor (U0126, 10 µM), PI3K inhibitor (LY294002, 1–50 µM), p38 inhibitor (SB203580, 0.1–10 µM) or DMSO alone as negative control, for 1 hr prior to stimulation with NS5A (0.5 µg/ml) for additional 24 h. Supernatants were assayed for IL-10 content by ELISA. Results represent the percentage of inhibition of IL-10 production, and are the mean ± SEM of 3 separate experiments. * P<0.01.](https://figures.cochat.ai/paper-figures/88424d6dbca04d50953954fe9fa93795/hepatitis-c-virus-hcv-evades-nkg2d-dependent-nk-cell-responses-through-ns5a-figure-5.jpg)
![Figure 6 Supernatants of HCV-infected Huh-7.5.1 cells reproduce the effect of recombinant NS5A. A) Control PBMCs were cultured for 48 hr in medium alone, in medium containing 0.5 µg/ml of recombinant NS5A, or in medium containing 50% of supernatant from non-infected or JFH1-replicating Huh-7.5.1 cells (collected at day 3, 13, 15 or 18 post transfection). NKG2D expression on NK cells was analyzed 48 hr later by flow cytometry. * P<0.05, ** P = 10−4 for comparison with the values in medium alone. B) Control monocytes were incubated for 30 min at 4°C with supernatants from non-infected or JFH1-infected Huh-7.5.1 cells collected at the indicated day post infection, or with 0.5 µg/ml of recombinant NS4 or NS5A proteins as negative and positive controls, respectively. Binding of NS5A to monocytes was revealed by staining with anti-NS5A 9E10 antibody and flow cytometry analysis. Results are expressed as the index of binding ([% binding with culture supernatant - % binding with medium alone]/% binding with medium alone), and represent mean ± SEM of 2 independent experiments. C) NKG2D expression on liver-infiltrating NK cells from HCV patients. Left panel: Representative NKG2D staining in paired circulating and liver-infiltrating NK cells freshly isolated from one chronically infected HCV patient. Dot plots and corresponding histograms show the frequency of NK cells (boxed CD3-CD56+) and their NKG2D expression. Right panel: NKG2D staining with anti-NKG2D mAb in liver biopsy from a chronically HCV-infected patient. Results are representative of 4 HCV patients. Only few NKG2D-positive cells (arrows) are found within a mononuclear infiltrate surrounding a portal tract. Original magnification, ×40.](https://figures.cochat.ai/paper-figures/31286c58f8954a79b6a1c4412c7ded48/hepatitis-c-virus-hcv-evades-nkg2d-dependent-nk-cell-responses-through-ns5a-figure-6.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the liver, hepatic stress caused by hepatitis B and C virus infection was associated with the induction of ligands for the activating receptor NKG2D (18,19).”
From NKG2D-mediated detection of metabolically stressed hepatocytes by innate-like T cells is essential for initiation of NASH and fibrosis (2023) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312 · cited 1×
“TLR4 signaling results in the downstream activation of NF-kB, MAPK (p38 and JNK) and PI3K pathways [28].”
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999 · cited 1×
“of NKG2D-positive NK cells in controls (60%) from Oliviero’s study, although NKG2D is usually reported to be constitutively expressed on all NK cells [12].”
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769 · cited 1×
“inhibitory and activating receptors [2].”
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754 · cited 3×
“1 hepatoma cells transfected or not with the infectious genotype 2a JHF1 replicon [34,35].”
Complete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238 · cited 2×
“After washing and blocking with human IgG, cells were incubated for 40 min at 4°C with the mouse 9E10 mAb specific for genotype 2a NS5A (a generous gift from C.M. Rice, Rockefeller University, NY, USA) [74], followed with PE-labeled goat anti-mouse Ig, and analyzed by flow cytometry.”
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709 · cited 3×
“1 hepatoma cells transfected or not with the infectious genotype 2a JHF1 replicon [34,35].”
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592 · cited 2×
“Soluble TGFb is associated with NKG2D reduction Systemic NKG2D downregulation on immune effector cells has been related to the release of soluble factors such as MIC molecules (sMIC) in the serum of cancer patients [13].”
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179 · cited 1×
“influence of genetic polymorphisms of KIR and their HLA ligands on the outcome of HCV infection [4].”
Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Meresse, B., Chen, Z., Ciszewski, C., Tretiakova, M., Bhagat, G., Krausz, T. N., Raulet, D. H., Lanier, L. L., Groh, V., Spies, T., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.020 · Cited by 855 · cited 1×
“In contrast with TGFβ, IL-15 up-regulates surface NKG2D expression [40].”
Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M. P., Greten, T. F., & Korangy, F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.020 · Cited by 793 · cited 1×
“Furthermore, MDSCs were recently shown to inhibit NK cell functions through direct cell-cell contact in the context of hepatocellular carcinoma in humans [60,61].”
Li, H., Han, Y., Guo, Q., Zhang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.240 · Cited by 777 · cited 1×
“bound TGFβ and direct contact with NK cells [59].”
A Direct Role for NKG2D/MICA Interaction in Villous Atrophy during Celiac Disease
Hüe, S., Mention, J.-J., Monteiro, R. C., Zhang, S., Cellier, C., Schmitz, J., Verkarre, V., Fodil, N., Bahram, S., Cerf-Bensussan, N., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.018 · Cited by 759 · cited 1×
“Paraffin-embedded liver biopsy sections (12 patients) were stained with anti-MIC (clone SR99 [75]) or anti-NKG2D (R&D Systems) mAb, followed with biotinylated goat anti-mouse Ig.”
Self-citationCastriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730640100 · Cited by 726
Host Immune System Gene Targeting by a Viral miRNA
Stern-Ginossar, N., Elefant, N., Zimmermann, A., Wolf, D. G., Saleh, N., Biton, M., Horwitz, E., Prokocimer, Z., Prichard, M., Hahn, G., et al. (2007) · Science · doi:10.1126/science.1140956 · Cited by 645 · cited 2×
“Different virally encoded products have been shown to impair NKG2D-mediated detection of infected cells, usually by targeting the ligands of NKG2D rather than the receptor itself [14,16,53,54].”
Hoechst, B., Voigtlaender, T., Ormandy, L., Gamrekelashvili, J., Zhao, F., Wedemeyer, H., Lehner, F., Manns, M. P., Greten, T. F., & Korangy, F. (2009) · Hepatology · doi:10.1002/hep.23054 · Cited by 643 · cited 1×
“Furthermore, MDSCs were recently shown to inhibit NK cell functions through direct cell-cell contact in the context of hepatocellular carcinoma in humans [60,61].”
Evasion of intracellular host defence by hepatitis C virus
Gale, M., & Foy, E. M. (2005) · Nature · doi:10.1038/nature04078 · Cited by 633 · cited 1×
“responses, a significant number of which target the innate system [45,46].”
Lee, J.-C., Lee, K.-M., Kim, D.-W., & Heo, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7335 · Cited by 549 · cited 1×
“TGFb is another mediator of systemic NKG2D downregulation [21,22,23].”
PI3K-mediated negative feedback regulation of IL-12 production in DCs
Fukao, T., Tanabe, M., Terauchi, Y., Ota, T., Matsuda, S., Asano, T., Kadowaki, T., Takeuchi, T., & Koyasu, S. (2002) · Nature Immunology · doi:10.1038/ni825 · Cited by 529 · cited 1×
“TLR4 activation may contribute to IL-10 production via p38 and PI3K [29], while PI3K is an endogenous suppressor of IL-12 production triggered by TLR4 [30].”
Bryceson, Y. T., March, M. E., Barber, D. F., Ljunggren, H.-G., & Long, E. O. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051143 · Cited by 515 · cited 1×
“cells, and measured NK cell degranulation rather than overall K562 cell lysis, because it has the advantage to shift the focus from the fate of target cells to the true response of NK cells, as previously demonstrated [52].”
Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 Signaling
Bieback, K., Lien, E., Klagge, I. M., Avota, E., Schneider-Schaulies, J., Duprex, W. P., Wagner, H., Kirschning, C. J., ter Meulen, V., & Schneider-Schaulies, S. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8729-8736.2002 · Cited by 509 · cited 1×
“In particular, TLR2 and TLR4 are involved in extracellular sensing of several viral proteins by monocytes and dendritic cells [25,26,27].”
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413 · cited 1×
“orchestrate the adaptive immune response towards Th1-type antiviral immunity [1].”
Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., De Filippi, F., Bruno, S., & Mondelli, M. U. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.047 · Cited by 412 · cited 4×
“([10,38,39]- liver NK cells expressed higher NKG2D levels than their circulating counterpart (mean MFI 115.”
InfluentialResident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes
Norris, S., Collins, C., Doherty, D. G., Smith, F., McEntee, G., Traynor, O., Nolan, N., Hegarty, J., & O'Farrelly, C. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80206-7 · Cited by 374 · cited 1×
“NK cells abound in the normal liver, where they make up to 30% of resident hepatic lymphocytes [3].”
Ma, W., Lim, W., Gee, K., Aucoin, S., Nandan, D., Kozlowski, M., Diaz-Mitoma, F., & Kumar, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011157200 · Cited by 308 · cited 5×
“TLR4 signaling results in the downstream activation of NF-kB, MAPK (p38 and JNK) and PI3K pathways [28].”
InfluentialMortier, E., Quéméner, A., Vusio, P., Lorenzen, I., Boublik, Y., Grötzinger, J., Plet, A., & Jacques, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508624200 · Cited by 308 · cited 1×
“Rather, we propose the use of IL-15 or biologically active soluble IL-15/IL-15Ra complexes [69] - as an adjuvant therapeutic agent to restore NKG2D-mediated NK cell functions.”
Friese, M. A., Wischhusen, J., Wick, W., Weiler, M., Eisele, G., Steinle, A., & Weller, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1627 · Cited by 305
Yu, J., Wei, M., Becknell, B., Trotta, R., Liu, S., Boyd, Z., Jaung, M. S., Blaser, B. W., Sun, J., Benson, D. M., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.016 · Cited by 279 · cited 2×
“Because of the reciprocal antagonism of IL-15 and TGFb on intracellular signaling pathways [41,42,43], we wondered if decreased NKG2D expression on circulating NK cells”
Lodoen, M., Ogasawara, K., Hamerman, J. A., Arase, H., Houchins, J. P., Mocarski, E. S., & Lanier, L. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021973 · Cited by 275 · cited 2×
“Different virally-encoded products have been shown to impair NKG2D-mediated detection of infected cells, usually by targeting the ligands of NKG2D rather than the receptor itself [14,16,53,54].”
Ahlenstiel, G., Titerence, R. H., Koh, C., Edlich, B., Feld, J. J., Rotman, Y., Ghany, M. G., Hoofnagle, J. H., Liang, T. J., Heller, T., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.08.066 · Cited by 270
Dolganiuc, A., Kodys, K., Kopasz, A., Marshall, C., Do, T., Romics, L., Mandrekar, P., Zapp, M., & Szabo, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5615 · Cited by 255 · cited 1×
“Previous studied identified that HCV core, NS3 or NS4, but not E2 protein induced monocytederived IL-10 production [56,57].”
Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost
Zhong, J., Gastaminza, P., Chung, J., Stamataki, Z., Isogawa, M., Cheng, G., McKeating, J. A., & Chisari, F. V. (2006) · Journal of Virology · doi:10.1128/jvi.01307-06 · Cited by 253 · cited 3×
“However, there is now increasing evidence that HCV mediates hepatocyte apoptosis [31,32,33,65,66], which may allow HCV proteins to be released in the extracellular milieu.”
Nattermann, J., Feldmann, G., Ahlenstiel, G., Langhans, B., Sauerbruch, T., & Spengler, U. (2006) · Gut · doi:10.1136/gut.2005.076463 · Cited by 236 · cited 2×
“Indeed, reduced NKp30 levels have been observed on NK cells from HCV patients [6].”
Tieng, V., Le Bouguénec, C., du Merle, L., Bertheau, P., Desreumaux, P., Janin, A., Charron, D., & Toubert, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032668099 · Cited by 235 · cited 1×
“MIC proteins are induced at the cell surface upon exposure to various pathogens [11,18,19,20], serving as a warning signal that alerts NK cells to mediate effector functions through NKG2D signaling.”
Kinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K., Takaki, H., Himeno, K., Takaesu, G., Kobayashi, T., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052333 · Cited by 225 · cited 1×
“IL-10 signaling activates STAT3, which positively regulates TGFb promoter activity [55].”
De Maria, A., Fogli, M., Mazza, S., Basso, M., Picciotto, A., Costa, P., Congia, S., Mingari, M. C., & Moretta, L. (2007) · European Journal of Immunology · doi:10.1002/eji.200635989 · Cited by 220 · cited 2×
“The overall contribution of the NKG2D pathway in the control of HCV infection is unclear [7,10].”
Chang, S., Dolganiuc, A., & Szabo, G. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207128 · Cited by 206 · cited 1×
“In the case of core and NS3, this effect was mediated through TLR2 signaling [58].”
Benahmed, M., Meresse, B., Arnulf, B., Barbe, U., Mention, J., Verkarre, V., Allez, M., Cellier, C., Hermine, O., & Cerf–Bensussan, N. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.025 · Cited by 191 · cited 2×
“reciprocal antagonism of IL-15 and TGFβ on intracellular signaling pathways [41,42,43], we”
Rölle, A., Mousavi-Jazi, M., Eriksson, M., Odeberg, J., Söderberg-Nauclér, C., Cosman, D., Kärre, K., & Cerboni, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.902 · Cited by 186 · cited 1×
“The importance of the NKG2D defense system is highlighted by the observation that tumors and viruses have developed several mechanisms for evading NKG2D-mediated recognition [13,14,15,16,17].”
Cerboni, C., Neri, F., Casartelli, N., Zingoni, A., Cosman, D., Rossi, P., Santoni, A., & Doria, M. (2007) · Journal of General Virology · doi:10.1099/vir.0.82125-0 · Cited by 177 · cited 1×
“Different virally encoded products have been shown to impair NKG2D-mediated detection of infected cells, usually by targeting the ligands of NKG2D rather than the receptor itself [14,16,53,54].”
Thomas, M., Boname, J. M., Field, S., Nejentsev, S., Salio, M., Cerundolo, V., Wills, M., & Lehner, P. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707883105 · Cited by 176 · cited 1×
“Different virally-encoded products have been shown to impair NKG2D-mediated detection of infected cells, usually by targeting the ligands of NKG2D rather than the receptor itself [14,16,53,54].”
Sandau, M. M., Schluns, K. S., Lefrancois, L., & Jameson, S. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6537 · Cited by 175 · cited 1×
“IL-15/IL-15Rα complexes [44], so that free IL-15 is unlikely to represent a reliable marker of systemic IL-15 production.”
Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing
Morishima, C., Paschal, D. M., Wang, C. C., Yoshihara, C. S., Wood, B. L., Yeo, A. E. T., Emerson, S. S., Shuhart, M. C., & Gretch, D. R. (2006) · Hepatology · doi:10.1002/hep.21073 · Cited by 174 · cited 1×
“Some previous studies have reported defective NK cell function in HCV infection [47,48,49], although others have not seen this [5,50,51].”
Meier, U.-C., Owen, R. E., Taylor, E., Worth, A., Naoumov, N., Willberg, C., Tang, K., Newton, P., Pellegrino, P., Williams, I., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12365-12374.2005 · Cited by 174 · cited 1×
“Some previous studies have reported defective NK cell function in HCV infection [47,48,49], although others have not seen this [5,50,51].”
NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
Horng, T., Bezbradica, J. S., & Medzhitov, R. (2007) · Nature Immunology · doi:10.1038/ni1524 · Cited by 168 · cited 1×
“Notably, the pathways triggered by IL-15 receptor signaling are required for the NKG2D-mediated signal transduction and cytotoxicity [70].”
Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Groh, V., Spies, T., Suzuki, T., Miyagi, T., & Hayashi, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5423 · Cited by 165 · cited 1×
“showed that dendritic cells (DCs) from HCV-infected patients have impaired IL-15 production upon stimulation by IFNa [71].”
Bonorino, P., Ramzan, M., Camous, X., Dufeu‐Duchesne, T., Thelu, M. A., Stürm, N., Dariz, A., Guillermet, C., Pernollet, M., Zarski, J., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.030 · Cited by 158 · cited 2×
“7%), as already reported in HCV-infected livers [9,36,37].”
Self-citationKrmpotic, A., Hasan, M., Loewendorf, A., Saulig, T., Halenius, A., Lenac, T., Polic, B., Bubic, I., Kriegeskorte, A., Pernjak-Pugel, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041617 · Cited by 149 · cited 1×
“The importance of the NKG2D defense system is highlighted by the observation that tumors and viruses have developed several mechanisms for evading NKG2Dmediated recognition [13,14,15,16,17].”
Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection
CORADO, J., TORO, F., RIVERA, H., BIANCO, N. E., DEIBIS, L., & DE SANCTIS, J. B. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1997.4581355.x · Cited by 148 · cited 1×
“Some previous studies have reported defective NK cell function in HCV infection [47,48,49], although others have not seen this [5,50,51].”
Brady, M. T., MacDonald, A. J., Rowan, A. G., & Mills, K. H. G. (2003) · European Journal of Immunology · doi:10.1002/eji.200324251 · Cited by 145 · cited 1×
“Previous studied identified that HCV core, NS3 or NS4, but not E2 protein induced monocyte-derived IL-10 production [56,57].”
Golden-Mason, L., Madrigal-Estebas, L., McGrath, E., Conroy, M. J., Ryan, E. J., Hegarty, J. E., O’Farrelly, C., & Doherty, D. G. (2008) · Gut · doi:10.1136/gut.2007.130963 · Cited by 144 · cited 2×
“Some previous studies have reported defective NK cell function in HCV infection [47,48,49], although others have not seen this [5,50,51].”
Walters, K., Syder, A. J., Lederer, S., Diamond, D. L., Paeper, B. W., Rice, C. M., & Katze, M. G. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000269 · Cited by 135 · cited 2×
“However, there is now increasing evidence that HCV mediates hepatocyte apoptosis [31,32,33,65,66], which may allow HCV proteins to be released in the extracellular milieu.”
Lambert, S. L., & Martinez, O. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8225 · Cited by 120 · cited 1×
“The LMP1 protein of EBV also induces IL-10 via p38 and PI3 kinase activation [63].”
Natural killer cells: Primary target for hepatitis C virus immune evasion strategies?
Golden‐Mason, L., & Rosen, H. R. (2006) · Liver Transplantation · doi:10.1002/lt.20708 · Cited by 119 · cited 1×
“responses, a significant number of which target the innate system [45,46].”
Abel, M., Sène, D., Pol, S., Bourlière, M., Poynard, T., Charlotte, F., Cacoub, P., & Caillat-Zucman, S. (2006) · Hepatology · doi:10.1002/hep.21438 · Cited by 117 · cited 1×
“However, there is now increasing evidence that HCV mediates hepatocyte apoptosis [31,32,33,65,66], which may allow HCV proteins to be released in the extracellular milieu.”
Self-citationGolden-Mason, L., Klarquist, J., Wahed, A. S., & Rosen, H. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3637 · Cited by 110 · cited 1×
“This phenomenon might be favored by the abnormal expression of the Programmed-Death 1 (PD-1) molecule on NK cells, which has been observed in chronically-infected HCV patients [68].”
Deignan, T., Curry, M. P., Doherty, D. G., Golden‐Mason, L., Volkov, Y., Norris, S., Nolan, N. P., Traynor, O., McEntee, G., Hegarty, J. E., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00072-7 · Cited by 98 · cited 1×
“7%), as already reported in HCV-infected livers [9,36,37].”
Pár, G., Rukavina, D., Podack, E. R., Horányi, M., Szekeres‐Barthó, J., Hegedűs, G., Paál, M., Szereday, L., Mózsik, G., & Pár, A. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00218-0 · Cited by 97 · cited 1×
“Some previous studies have reported defective NK cell function in HCV infection [47,48,49], although others have not seen this [5,50,51].”
Ebihara, T., Shingai, M., Matsumoto, M., Wakita, T., & Seya, T. (2008) · Hepatology · doi:10.1002/hep.22337 · Cited by 87 · cited 2×
“However, there is now increasing evidence that HCV mediates hepatocyte apoptosis [31,32,33,65,66], which may allow HCV proteins to be released in the extracellular milieu.”
Datta, A., Sinha-Datta, U., Dhillon, N. K., Buch, S. J., & Nicot, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600684200 · Cited by 86 · cited 1×
“Interaction of HTLV-1 p30 protein with TLR4 signaling stimulates the release of IL-10 and hampers the release of pro-inflammatory cytokines from macrophages [25].”
Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10
Stöckl, J., Vetr, H., Majdic, O., Zlabinger, G. J., Kuechler, E., & Knapp, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7255 · Cited by 83 · cited 1×
“Human major group rhinoviruses [26] downmodulate the accessory function of monocytes by inducing IL-10 production and inhibiting IL-12 production.”
Walters, K., Joyce, M., Thompson, J. C., Smith, M. W., Yeh, M. M., Proll, S. C., Zhu, L.-F., Gao, T., Kneteman, N. M., Tyrrell, D. L., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020059 · Cited by 82 · cited 1×
“However, there is now increasing evidence that HCV mediates hepatocyte apoptosis [31,32,33,65,66], which may allow HCV proteins to be released in the extracellular milieu.”
Dann, S. M., Wang, H., Gambarin, K. J., Actor, J. K., Robinson, P., Lewis, D. E., Caillat‐Zucman, S., & White, Jr. (2005) · The Journal of Infectious Diseases · doi:10.1086/444393 · Cited by 78 · cited 1×
“MIC proteins are induced at the cell surface upon exposure to various pathogens [11,18,19,20], serving as a warning signal that alerts NK cells to mediate effector functions through NKG2D signaling.”
Self-citationGOLDEN-MASON, L., KELLY, A. M., DOHERTY, D. G., TRAYNOR, O., MCENTEE, G., KELLY, J., HEGARTY, J. E., & O'FARRELLY, C. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02586.x · Cited by 77 · cited 1×
“Expression of IL-15 within HCVinfected livers was reported to show a sinusoidal distribution [67].”
Maloney, G., Schröder, M., & Bowie, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501917200 · Cited by 75 · cited 2×
“The vaccinia virus A52R protein activates p38 and JNK, and promotes TLR4-induced IL-10 production, while inhibiting NFkBdependent genes IL-8 and RANTES [64].”
Gee, K., Angel, J. B., Mishra, S., Blahoianu, M. A., & Kumar, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.798 · Cited by 74 · cited 3×
“Gee K, Angel JB, Mishra S, Blahoianu MA, Kumar A (2007) IL-10 regulation by HIVTat in primary human monocytic cells: involvement of calmodulin/calmodulindependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors.”
Crotta, S., Ronconi, V., Ulivieri, C., Baldari, C. T., Valiente, N. M., Abrignani, S., & Wack, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535527 · Cited by 58 · cited 1×
“TGFb is secreted by monocytes upon stimulation by the HCV-NS5A protein Engagement of the HCV receptor CD81 by the major HCV envelope protein E2 was shown to block NK cell functions triggered by NKG2D engagement [24].”
Yamagiwa, S., Matsuda, Y., Ichida, T., Honda, Y., Takamura, M., Sugahara, S., Ishikawa, T., Ohkoshi, S., Sato, Y., & Aoyagi, Y. (2008) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00317.x · Cited by 57 · cited 1×
“7%), as already reported in HCV-infected livers [9,36,37].”
Kottilil, S., Yan, M. Y., Reitano, K. N., Zhang, X., Lempicki, R. A., Roby, G. A., Daucher, M., Yang, J., Cortez, K. J., Ghany, M. G., et al. (2009) · Hepatology · doi:10.1002/hep.23055 · Cited by 55 · cited 2×
“MIC proteins are induced at the cell surface upon exposure to various pathogens [11,18,19,20], serving as a warning signal that alerts NK cells to mediate effector functions through NKG2D signaling.”
Hüe, S., Monteiro, R. C., Berrih-Aknin, S., & Caillat-Zucman, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1909 · Cited by 54 · cited 1×
“Soluble MICA was measured in the sera with a sandwich ELISA as described [73].”
Self-citationConry, S. J., Milkovich, K. A., Yonkers, N. L., Rodriguez, B. A., Bernstein, H. B., Asaad, R. J., Heinzel, F. P., Tary‐Lehmann, M., Lederman, M. M., & Anthony, D. D. (2009) · Journal of Virology · doi:10.1128/jvi.00753-09 · Cited by 54 · cited 1×
“Some previous studies have reported defective NK cell function in HCV infection [47,48,49], although others have not seen this [5,50,51].”
Bonorino, P., Leroy, V., Dufeu‐Duchesne, T., Tongiani-Dashan, S., Stürm, N., Pernollet, M., Vivier, É., Zarski, J., Marche, P. N., & Jouvin‐Marche, E. (2007) · Hepatology · doi:10.1002/hep.21850 · Cited by 35 · cited 1×
“reported [72] and processed immediately for staining and flow cytometry.”
Self-citationLucas, P. J., Kim, S., Mackall, C. L., Telford, W. G., Chu, Y., Hakim, F. T., & Gress, R. E. (2006) · Blood · doi:10.1182/blood-2006-05-025676 · Cited by 33 · cited 2×
“Because of the reciprocal antagonism of IL-15 and TGFb on intracellular signaling pathways [41,42,43], we wondered if decreased NKG2D expression on circulating NK cells”
Pár, G., Rukavina, D., Podack, E. R., et al. (2002) · Cited by 28
Kennedy, P. T. F., Gehring, A. J., Nowbath, A., Selden, C., Quaglia, A., Dhillon, A. P., Dusheiko, G. M., & Bertoletti, A. (2008) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01049.x · Cited by 20 · cited 2×
“([10,38,39]- liver NK cells expressed higher NKG2D levels than their circulating counterpart (mean MFI 115.”
Vermijlen, D., Seynaeve, C., Luo, D., Kruhøffer, M., Eizirik, D. L., Orntoft, T. F., & Wisse, E. (2004) · European Journal of Immunology · doi:10.1002/eji.200324712 · Cited by 17 · cited 1×
“line with previous observations in the rat and human ([10,38,39]- liver NK cells expressed higher NKG2D levels than their circulating counterpart (mean MFI 115.”
Cited by
Living in the liver: hepatic infections
Protzer, U., Maini, M. K., & Knolle, P. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3169 · Cited by 560
Natural killer cells in antiviral immunity
Björkström, N. K., Strunz, B., & Ljunggren, H.-G. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00558-3 · Cited by 503
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3251 · Cited by 468
Innate and adaptive immune responses in HCV infections
Heim, M. H., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.035 · Cited by 305
“For example, a recent report suggests that NS5A-containing apoptotic bodies can trigger monocytes to produce increased amounts of IL-10 and decreased levels of IL-12 that leads to a significant downregulation of NKG2D on NK cells via TGF-b [103].”
BackgroundNatural killer cells in liver disease
Tian, Z., Chen, Y., & Gao, B. (2013) · Hepatology · doi:10.1002/hep.26115 · Cited by 290
“Suppression of intrahepatic NK cell functions may be the result of either cell-to-cell contact with HCVinfected hepatocytes(60) or TGF-b production from HCV protein-stimulated monocytes.(45) Further studies are required to clarify functions of intrahepatic NK cells during chronic HCV infection.”
Background
Metadata
- Authors
- Sène, D., Levasseur, F., Abel, M., Lambert, M., Camous, X., Hernandez, C., Pène, V., Rosenberg, A. R., Jouvin-Marche, E., Marche, P. N., Cacoub, P., & Caillat-Zucman, S.
- Affiliations
- Inserm (FR)
- Université Paris Descartes (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-11-11
- Volume
- 6
- Issue
- 11
- Pages
- e1001184
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2978723
- OpenAlex
- W1968304159
- Cited by
- 113
- References
- 78
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 11 · 2018: 8 · 2017: 11 · 2016: 5 · 2015: 14 · 2014: 10 · 2013: 11 · 2012: 12
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- hepatitis C virus, NKG2D, natural killer cells, NS5A, immune evasion, IL-10, IL-12, TGF-beta, IL-15, TLR4, p38 MAPK, PI3-kinase, interferon-gamma, chronic hepatitis C, hepatocytes
- MeSH terms
- Adult, Aged, Cytotoxicity, Immunologic, Female, Flow Cytometry, Humans, Immunity, Cellular, Killer Cells, Natural, Liver Cirrhosis, Male, Middle Aged, Monocytes, RNA-Dependent RNA Polymerase, Virus Replication, Hepacivirus, Cytokines, Viral Nonstructural Proteins, Inflammation Mediators, Hepatitis C, Chronic, NK Cell Lectin-Like Receptor Subfamily K, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.